MedPath

Role of certain oral drug, medicated oil through rectal and topical (ear) route in sensorineural hearing loss

Phase 2
Conditions
Health Condition 1: H905- Unspecified sensorineural hearingloss
Registration Number
CTRI/2019/07/020096
Lead Sponsor
ational Institute of Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients having specific signs and symptoms of Badhirya (SNHL) as per Ayurvedic and modern parameters will be registered.

Exclusion Criteria

1. Patients having congenital hearing loss.

2. Patients having history of long term intake of ototoxic drugs.

3. Pregnant women.

4. Patients suffering from systemic diseases like uncontrolled diabetes mellitus, Tuberculosis, Hypertension, Meniereâ??s disease, Otosclerosis, Labyrinthitis etc.

5. Patients with tympanic membrane perforation.

6. Genetic SNHL.

7. Psychogenic hearing loss.

8. Degree of hearing loss greater than 80 dB.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in the investigator assessment score for <br/ ><br>decrease in the degree of hearing lossTimepoint: 2 months
Secondary Outcome Measures
NameTimeMethod
Any adverse event reported voluntarily,observed <br/ ><br>or enquiredTimepoint: 2 months
© Copyright 2025. All Rights Reserved by MedPath